Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FDD4J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,763
Award facts
- Contract value 100% obligated
- $10,762.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,762.74 to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-count units) on February 4, 2026, with completion scheduled for February 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for rheumatoid arthritis and other inflammatory conditions, representing routine pharmaceutical procurement to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at up to $999,999,999.00 through December 2031. The IDC serves as a global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs and other federal medical institutions. AmerisourceBergen, as one of the nation's largest pharmaceutical distributors, regularly fulfills such delivery orders across multiple therapeutic domains to meet the federal government's ongoing medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FDD4J?
SPE2DR26FDD4J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FDD4J worth?
The government has obligated $10,763 on SPE2DR26FDD4J.
Is contract SPE2DR26FDD4J an order under another contract?
Yes. SPE2DR26FDD4J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDD4J competed?
The extent of competition for SPE2DR26FDD4J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award